Charles Schwab, IBD Stock Of The Day, Eyes Buy Point After Earnings, Upgrade
In This Article:
Charles Schwab stock climbs toward a buy point following an upgrade from Goldman Sachs, Q1 earnings beat. Shares are up 8.5% in 2025.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Charles Schwab stock climbs toward a buy point following an upgrade from Goldman Sachs, Q1 earnings beat. Shares are up 8.5% in 2025.